Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hejna

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Cancer|May 17, 2000
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIEM Raderer, J Valencak, C Osterreicher, et al.
Journal of the National Cancer Institute|April 28, 1999
Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue typeM Raderer, J Valencak, F Pfeffel, et al.
British Journal of Cancer|September 23, 1998
Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factorG V Kornek, K Haider, W Kwasny, et al.
Cancer|October 15, 1996
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinomaM Hejna, G V Kornek, A U Schratter-Sehn, et al.
Cancer Biology & Therapy|December 19, 2017
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysisA Ilhan-Mutlu, H Taghizadeh, A Beer, et al.
Cancer|August 10, 2000
Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factorM Hejna, G V Kornek, M Raderer, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Soluble ICAM-1 in breast cancer: clinical significance and biological implicationsW J Köstler, S Tomek, T Brodowicz, et al.
Oncology|October 21, 1998
Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinomaM Hejna, G V Kornek, M Raderer, et al.
British Journal of Cancer|November 1, 1996
Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factorG V Kornek, K Haider, W Kwasny, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Combined irinotecan and oxaliplatin plus granulocyte colony-stimulating factor in patients with advanced fluoropyrimidine/leucovorin-pretreated colorectal cancerW Scheithauer, G V Kornek, M Raderer, et al.
Cancer|May 17, 2000
Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified Ann Arbor Stages IE and IIEM Raderer, J Valencak, C Osterreicher, et al.
Journal of the National Cancer Institute|April 28, 1999
Somatostatin receptor expression in primary gastric versus nongastric extranodal B-cell lymphoma of mucosa-associated lymphoid tissue typeM Raderer, J Valencak, F Pfeffel, et al.
British Journal of Cancer|September 23, 1998
Effective treatment of advanced breast cancer with vinorelbine, 5-fluorouracil and l-leucovorin plus human granulocyte colony-stimulating factorG V Kornek, K Haider, W Kwasny, et al.
Cancer|October 15, 1996
Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinomaM Hejna, G V Kornek, A U Schratter-Sehn, et al.
Cancer Biology & Therapy|December 19, 2017
Correlation of trastuzumab-based treatment with clinical characteristics and prognosis in HER2-positive gastric and gastroesophageal junction cancer: A retrospective single center analysisA Ilhan-Mutlu, H Taghizadeh, A Beer, et al.
Cancer|August 10, 2000
Treatment of patients with advanced nonsmall cell lung carcinoma using docetaxel and gemcitabine plus granulocyte-colony stimulating factorM Hejna, G V Kornek, M Raderer, et al.
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Soluble ICAM-1 in breast cancer: clinical significance and biological implicationsW J Köstler, S Tomek, T Brodowicz, et al.
Oncology|October 21, 1998
Mitomycin C, vinorelbine, carboplatin plus granulocyte-macrophage colony-stimulating factor for treatment of advanced non-small cell lung carcinomaM Hejna, G V Kornek, M Raderer, et al.
British Journal of Cancer|November 1, 1996
Effective treatment of advanced breast cancer with vinorelbine, mitomycin C plus human granulocyte colony-stimulating factorG V Kornek, K Haider, W Kwasny, et al.
Pageof 6